StockData
PMGC Holdings Inc. logo

PMGC Holdings Inc. (ELAB) stock

ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$2.83+0.06 (+2.17%)

Close on Oct 19, 2026Market cap $2.26MP/E –Yield –

PMGC free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

PMGC's free cash flow for the twelve months ending Sep 30, 2026 was -$10.02M. For fiscal 2025 it was -$6.38M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.38M–
FY2024Dec 31, 2024-$5.50M–
FY2023Dec 31, 2023-$4.57M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$2.62M–
Q2 FY2026Jun 30, 2026-$1.96M–
Q1 FY2026Mar 31, 2026-$3.34M–
Q4 FY2025Dec 31, 2025-$2.10M–
Q4 FY2024Dec 31, 2024-$2.00M–
Q3 FY2024Sep 30, 2024-$381.68K–
Q2 FY2024Jun 30, 2024-$780.69K–
Q1 FY2024Mar 31, 2024-$2.33M–
Q4 FY2023Dec 31, 2023-$2.39M–
Q3 FY2023Sep 30, 2023-$514.40K–
Q2 FY2023Jun 30, 2023-$768.76K–
Q1 FY2023Mar 31, 2023-$896.70K–

More PMGC figures

See a number that looks wrong?